- About this researcher
Weiqiang Zhao, MD
Professor
Pathology
Academic contact
2001 Polaris Pkwy
Columbus, OH 43240-2000
Phone: 614-293-4210
Academic information
- Department: Pathology
Research interests
- Medical Education
About
Biography
In addition to my clinical responsibilities, I am committed to advancing the field of pathology through education and research. As a clinical professor in the Department of Pathology, I mentor medical students and residents and contribute to innovations that improve diagnostic accuracy and patient outcomes. I am certified by the American Board of Pathology in Anatomic & Clinical Pathology, Hematopathology, and Molecular Genetic Pathology.
Credentials
Education
- Fellowship - Medical Genetics, Clinical Molecular Genetics
-
University of Texas MD Anderson Cancer Center, Houston, TX, United States
2/1/2006 - 1/31/2007 - Fellowship - Hematopathology
-
Tulane Medical Center, New Orleans, LA, United States
1/1/2005 - 1/31/2006 - Residency - Pathology, Anatomic Pathology & Clinical Pathology
-
Tulane Medical Center, New Orleans, LA, United States
7/1/2001 - 1/31/2005 - Internship - Pathology, Anatomic Pathology & Clinical Pathology
-
Tulane Medical Center, New Orleans, LA, United States
7/1/2000 - 6/30/2001 - Fellowship - Other, Not Listed
-
Howard Hughes Medical Institute, Chevy Chase, MD, USA
10/1/1998 - 10/8/1999 - Doctor of Philosophy
-
Tulane University School of Medicine, New Orleans, LA, United States
8/1/1993 - 10/31/1998 - Fellowship - Other, Not Listed
-
Tulane Medical Center, New Orleans, LA, United States
6/1/1992 - 6/30/1993 - Doctor of Medicine (MD)
-
Hunan Medical University, Chan, Hunan, China
2/1/1978 - 12/31/1982
Certifications
-
American Board of Pathology Hematopathology
1/1/2019 -
American Board of Pathology/Molecular Genetic
9/11/2009 -
American Board of Pathology/Anatomic & Clinical
11/18/2005
Research
Research interests
- Medical Education
More about my research
News and media
My news coverage
- Multi-gene testing could detect more hereditary cancer syndromes
- Single Upfront Genomic Test Improves Lynch Syndrome Detection Rates
- Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families
- Inhibition of CDK4 Might Promote Lymphoma Development and Progression
- Next-Generation Genome Screening Is Step Toward Precision Cancer Medicine for Lung Cancer
- Targeted Agent Shows Promise For Chronic Lymphoid Leukemia
